2.2(top 8%)
Impact Factor
2.3(top 8%)
extended IF
94(top 4%)
H-Index
607
authors
2.3K
papers
56.9K
citations
3.3K
citing journals
16.3K
citing authors

Most Cited Articles of International Clinical Psychopharmacology

TitleYearCitations
The measurement of disability1996910
Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)1994341
Depression in the community1997313
A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder2012283
Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT(2C) antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study2002271
Antioxidant enzyme activities and oxidative stress in affective disorders2004267
Efficacy of treatments for anxiety disorders: a meta-analysis2015250
Biological rhythm disturbances in mood disorders2006244
A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500)2002243
Assessing treatment effects in clinical trials with the discan metric of the Sheehan Disability Scale2008237
A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. The Venlafaxine French Inpatient Study Group1994216
Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale1995207
Imputing response rates from means and standard deviations in meta-analyses2005199
Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder; a double-blind comparative study with fluvoxamine and maprotiline1988199
The social and economic burden of treatment-resistant schizophrenia: a systematic literature review2014195
Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey2000192
Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates1994190
A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables1995189
The GRID-HAMD: standardization of the Hamilton Depression Rating Scale2008179
Sexual problems in healthy and depressed persons1998173
Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study2006172
Equivalence of St John's wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mild-moderate depression2000171
The effects of D- and L-fenfluramine (and their interactions with D-amphetamine) on psychomotor function and mood1996169
Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial2007166
Impulsive aggression and central serotonergic system function in humans: an example of a dimensional brain-behavior relationship1992164